Polish Pharmaceuticals & Biotech Potentially Undervalued Companies

Selvita

Market Cap: zł526.8m

Provides drug discovery, drug development, and contract testing services in Poland.

Bayer

Market Cap: zł47.2b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Genomed Spólka Akcyjna

Market Cap: zł39.6m

Provides DNA and RNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

Novo Nordisk

Market Cap: zł1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Biogened

Market Cap: zł49.1m

Produces and sells cosmetics and toiletries in Poland.

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.

Eli Lilly

Market Cap: zł1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Ryvu Therapeutics

Market Cap: zł394.9m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.